Screening for colorectal neoplasia with faecal tests

The Lancet Oncology

Volumn 12, Issue 6, 2011, Pages 516-517

  Fraser, Callum G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER SCREENING; COLONOSCOPY; COLORECTAL TUMOR; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LETTER; LIMIT OF DETECTION; OCCULT BLOOD TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; OCCULT BLOOD;

EID: 79957488949     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70106-1     Document Type: Letter

References (5)

1. European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010, Publications Office of the European Union, Luxembourg. 1st edn. N. Segnan, J. Patnick, L. von Karsa (Eds.).
2. Fraser CG Fecal occult blood tests: life savers or outdated colorectal screening tools?. Clin Lab News 2011, 37:8-10.
3. Brenner H, Haug U, Hundt S Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010, 127:1643-1649.
4. sive Droste JS Terhaar, Oort FA, van der Hulst RWM, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev 2011, 20:272-280.
5. Chen L-S, Yen AM-F, Chiu SY-H, Liao C-S, Chen H-H Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011, published online May 17. 10.1016/S1470-2045(11)70101-2.